Applying Genetics and Genomics to Standard Cancer Care

December 2015 Vol 6, No 6

Jennifer R. Klemp, PhD, MPH, Founder/Chief Executive Officer, Cancer Survivorship Training, Associate Professor, Department of Medicine, Division of Clinical Oncology, Director, Cancer Survivorship Center, University of Kansas Cancer Center, The Richard and Annette Bloch Cancer Care Pavilion, Westwood, presented “Genetics and Genomics: How Does Navigation Fit In?” at the Sixth Annual Academy of Oncology Nurse & Patient Navigators (AONN+) Conference in Atlanta, GA. “The real role of genomic medicine and where we’re going is that we do want to be more personalized,” Dr Klemp said. “The larger panel in genomic testing is going to keep taking us in that direction.”

Dr Klemp focused on how navigators must be familiar with these terms, regardless of their role in their practice. “We need to be thinking about it during treatment and into posttreatment care, whether it’s lifestyle, surveillance, or dealing with disparities,” she said. “Risk assessment and genetic and genomic testing is part of that continuum of care, both for those who are disease- free, and for those who have been diagnosed with cancer and, as many of you know, other diseases.”

One gap in genetic testing that Dr Klemp highlighted includes follow-up time. “The biggest part of genetic testing, in my opinion, is that whether patients are positive or negative, they’re at high risk, or you wouldn’t have tested them,” she explained. “We need to have a system in place to help follow them and monitor them. We can collect blood or buccal; patients really like buccal— even our cancer patients—because it’s one less stick that they have to have. Those tests are equally as valid as those where we take the serum.”

Because genetic and genomic test results can determine whether a patient will need chemotherapy, Dr Klemp suggested allowing surgeons to order genetic testing to complete it earlier in the process so clinical decision- making can be more accurate. “It’s important because [even though] we are going to treat fewer patients with therapies…we are going to treat the right patients with the therapy,” she said. “If we wait until, unfortunately, they get to the oncologist, then there’s an additional lag time….The patient has expectations that once they see the oncologist, they’re going to get a plan. That doesn’t happen in a lot of these cases.”

She also proposed including genetic screening as part of wellness visits for the general population, as well as patients at high risk. “This process really needs to be thought of across the entire cancer continuum,” Dr Klemp emphasized. “It’s a very important push by the American Society of Clinical Oncology, as well. Not only are [we] talking about germline testing—really, we are talking about the whole gamut of genomic and genetic testing. This isn’t going away; it’s only going to be part of a standard of care.”

Related Articles
Keynote: Genetic Therapies Will Explode, Better Access to Data Will Drive Value
June 2022 Vol 13, No 6
Over the past 5 years, there have been 20 FDA approvals of novel genetic medicine technologies – and this is just the beginning. Here’s a glimpse of what’s coming ahead.
Empowering the Patient Voice: Genomic Testing and Cancer Care Decisions
Frank dela Rama, RN, MS, AOCNS, Sara Campbell, BS, BSN, OCN, Jim G.
|
Video Library
In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results.
2020 AONN+ Award Winners
January 2021 Vol 12, No 1
Each year, at the AONN+ annual conference, we pause to take note of the navigators and organizations among us who have made a significant impact in the field of oncology navigation. Although virtual, 2020 was no different, and it was with pride that we announced the 2020 class of AONN+ Award recipients. It is the distinct honor of the JONS Editorial Board and the AONN+ Leadership Council to recognize the navigators and organizations in our community who have made considerable contributions to our chosen specialty. This class of awardees includes a stellar group of navigators and organizations, each with their own unique and inspiring stories. Below, we tell their stories in the hope it provides inspiration to you in your professional life as an oncology nurse navigator or a patient navigator.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country